Acute respiratory distress syndrome (ARDS) is a potentially fatal condition where the lungs cannot provide enough oxygen to the body's vital organs. The condition, otherwise known as acute lung injury ...

Acute respiratory distress syndrome, also known as ARDS, is a common killer among critically ill patients hospitalized with COVID-19. But even if they survive, it’s a long road to recovery. Patients ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Back to Healio In patients hospitalized with COVID-19, ...

Inhaled sevoflurane significantly reduced ventilator-free days and 90-day survival versus IV propofol in moderate to severe ARDS. Inhaled volatile sedatives grew in popularity for prolonged use in ...

Please provide your email address to receive an email when new articles are posted on . Pulmonary hypertension plus acute respiratory distress syndrome resulted in poor hospital outcomes. Odds for ...

A recent study conducted by scientists from the Yokohama City University, Japan, has revealed that elevated alveolar endothelial injury markers in coronavirus disease 2019 (COVID-19) patients with ...

Supporting patients with acute respiratory distress syndrome (ARDS), remains a critical challenge in intensive care units ...

Acute respiratory distress syndrome (ARDS) has been associated with considerable morbidity and mortality, even before the COVID-19 pandemic hit. For the most part, ARDS management is limited to ...

Researchers at Endeavor Health and Northwestern University have created an artificial intelligence-based tool to help doctors recognize an underdiagnosed, often fatal respiratory syndrome found in ...

The rationale for subphenotyping acute respiratory distress syndrome (ARDS) arises from its marked biological and clinical ...